# ImmuneID

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/immuneid

- Industry: Biotechnology
- Headquarters: Cambridge, US
- Website: www.immuneidrx.com
- Total disclosed funding: $59M
- Latest round: Series A (Apr 27, 2021)
- Investors on record: 10

## About

Founded in 2020 and based in Massachusetts, US, ImmuneID, Inc. operates as a precision immunology company that developed a medical proprietary platform to identify antibody interactions for infectious diseases. The company was co-founded by Christoph Westphal and Lea Hachigian. ImmuneID, Inc. has a total of 2 funding rounds included the June 2021 Series A funding from Alta Partners, Alexandria Venture Investments, Redwood Capital Investments, Section 32, Tekla Capital Management, Arch Venture Partners, Longwood Fund, Pitango HealthTech, In-Q-Tel, Xfund, and other unspecified investors.

The company offers a comprehensive understanding of individual immune responses to employ massively parallel, multiplexed, and unbiased systems to identify therapeutically target millions of antibody interactions for severe allergy, oncology, and infectious disease.

In February 2021, the company plans to develop therapeutic programs in areas including severe allergy, autoimmunity, oncology, and infectious disease.

## Funding rounds

- Series A, Apr 27, 2021, $42M — Alta Partners, ARCH Venture Partners, Pitango, Alexandria Venture Investments, Tekla Capital Management, Longwood Fund, In-Q-Tel, Xfund, Section 32, Redwood Capital Investments
- Seed, Feb 16, 2021, $17M — ARCH Venture Partners, Pitango, Longwood Fund, In-Q-Tel, Xfund

## Investors

- ARCH Venture Partners (https://capitalatlas.ai/funds/arch-venture-partners) — Seed, Series A
- Pitango (https://capitalatlas.ai/funds/pitango) — Seed, Series A
- Longwood Fund (https://capitalatlas.ai/funds/longwood-fund) — Seed, Series A
- In-Q-Tel (https://capitalatlas.ai/funds/in-q-tel) — Seed, Series A
- Xfund (https://capitalatlas.ai/funds/xfund) — Seed, Series A
- Alta Partners (https://capitalatlas.ai/funds/alta-partners) — Series A
- Alexandria Venture Investments (https://capitalatlas.ai/funds/alexandria-venture-investments) — Series A
- Tekla Capital Management (https://capitalatlas.ai/funds/tekla-capital-management) — Series A
- Section 32 (https://capitalatlas.ai/funds/section-32) — Series A
- Redwood Capital Investments — Series A